Web23 mrt. 2024 · DURHAM, N.C., March 23, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Chief Executive Officer, and Rajiv Shukla, Alpha Healthcare Acquisition … Web11 apr. 2024 · DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced it has completed enrollment of a Phase 3 trial in hemodialysis access.
SEC Filing Humacyte, Inc.
Web12 aug. 2024 · Humacyte, Inc. (HUMA) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Humacyte, Inc. (HUMA) 10-Q Quarterly Report Fri Aug 12 2024; SEC Filings. HUMA Valuations. Intrinsic Value. … WebChairman and CEO, Humacyte, Inc. and former EVP and President, Global Pharmaceuticals, ... 2016 be included in Cardinal Health’s Annual Report on Form 10-K for filing with the SEC. ... how to night time potty train
Latest SEC filings for Humacyte, Inc. (HUMA) Seeking Alpha
Web10 jan. 2024 · Humacyte, Inc. (Exact name of registrant as specified in its charter) (919) 313-9633 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if … Web27 aug. 2024 · Insider trades for Humacyte, Inc. (HUMA). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. ... Filing Date Trade Date Ticker Insider Name Title Trade Type Price Qty Owned ΔOwn Value 1d 1w 1m 6m; 2024-12-19 … Web24 mrt. 2024 · Humacyte, Inc. Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited) (in thousands except for share and per share amounts) Three Months Ended December 31, Year Ended December 31, 2024 2024 … how to night photography